(A) | (B) | Â | Mean difference (A-B) | SE | 95% Confidence interval of difference | P-value | |
---|---|---|---|---|---|---|---|
 |  |  |  |  | Lower | Upper |  |
Baseline (HADSA) | End of 2nd week (HADSA) | Placebo | 0.37 | 0.28 | - 0.26 | 0.98 | 0.2 |
Bupropion | 1 | 0.3 | 0.3 | 1.7 | 0.009 | ||
End of 6th week (HADSA) | Placebo | 2.07 | 0.67 | 0.6 | 3.5 | 0.009 | |
Bupropion | 3.6 | 0.5 | 2.5 | 4.7 | 0.001> | ||
End of 2nd week (HADSA) | End of 6th week (HADSA) | Placebo | 1.7 | 0.6 | 0.4 | 3 | 0.014 |
Bupropion | 2.6 | 0.4 | 1.7 | 3.48 | 0.001> | ||
Baseline (HADSD) | End of 2nd week (HADSD) | Placebo | 0.57 | 0.29 | - 0.05 | 1.2 | 0.07 |
Bupropion | 1 | 0.25 | 0.4 | 1.5 | 0.002 | ||
End of 6th week (HADSD) | Placebo | 2.2 | 0.42 | 1.3 | 3.1 | 0.001> | |
Bupropion | 2.9 | 0.4 | 2 | 3.8 | 0.001> | ||
End of 2nd week (HADSD) | End of 6th week (HADSD) | Placebo | 1.64 | 0.4 | 0.7 | 2.5 | 0.002 |
Bupropion | 1.9 | 0.38 | 1 | 2.7 | 0.001> |